Over 100 advocacy organizations urge WH and Congress not to endanger Americans with importation of non-FDA approved drugs

Dear President Donald J. Trump, members of the United States Senate, and members of the United States House of Representatives:

As organizations that represent thousands of law enforcement, healthcare professionals, patient advocates, taxpayer organizations, business groups, and consumer interest groups, we are writing to express our deep concerns with and opposition to proposals to import non-FDA-approved medications that would endanger the health and safety of our communities…

[...]

Tampa Pharmacist Speaks Out Against Florida’s Drug Importation Proposal

This editorial by Dan Fucarino was published in Florida Politics on April 1, 2019. Mr Fucarino is the owner and a pharmacist at Carrollwood Compounding Center & Pharmacy.

“The monetary rewards of Canadian prescriptions are just not worth their safety risks,” he warns. “I urge Florida legislators to listen to health care experts on this issue rather than the understandable populist appeals and vote no on this dangerous legislation — and then get back to working on more productive ways to lower drug prices for Floridians. Thousands of Americans have been injured or killed by imported prescription drugs.”

[...]

Drug Importation Claim vs. Fact At Florida Senate Subcommittee Hearing

Experts and leadership from The Partnership for Safe Medicines were in Tallahassee, Florida on Monday, March 25th for a Senate hearing on an ill-advised Canadian drug importation bill. During the hearing, our team heard many false or misleading statements about the proposal to take medicine out of the Canadian medicine supply and ship it to Florida. Here’s a fact check of the most egregious ones…

[...]

Florida House Bill 19 Would Expose Patients To Unregulated Prescription Drugs

Concerns over how much constituents pay for their medications have caused multiple states to introduce bills that would legalize drug importation. Florida’s House Bill 19 is just one example of legislators thinking that stepping outside the security of the U.S.’s drug supply chain is a smart option for their state…

[...]